Leaps by Bayer
@LeapsByBayer
Breaking through the impossible in the life sciences. Leaps by Bayer aims to conquer 10 huge challenges facing humanity.
ID:925767482912182274
https://leaps.bayer.com 01-11-2017 16:52:22
1,1K Tweets
33,1K Followers
168 Following
🔍 Advances in #Alzheimers Genetics: Hundreds of thousands of people in the US alone could receive a diagnosis years before symptoms appear, allowing for earlier and potentially more effective interventions.
Read more: nytimes.com/2024/05/06/hea…
🔬 A unique enzyme found in #cyanobacteria enables them to efficiently capture CO2. Crucial for Earth's #carboncycle , these microorganisms could inspire #climateresilient crops, transforming agriculture. 🌱🌍
Read more: phys.org/news/2024-05-s…
🌱 Climate solutions face hurdles. Florida's cultured meat ban limits progress. Livestock emissions, esp. beef, are significant. Let's embrace sustainable choices and support innovation. 🌍🍽 #SustainableFood #ClimateAction #CulturedMeat
Read more: technologyreview.com/2024/05/07/109…
🎉Exciting news! Senti Biosciences starts patient dosing in Phase 1 trial of SENTI-202 for hematologic malignancies like AML. Potential game-changer in cancer treatment! 🚀 #ClinicalTrials #innovation
Read more: investors.sentibio.com/news-releases/…
'Who would have thought that gene therapy could restore hearing within a year? 👶 👂 🧬
Recent advancements in #genetherapy are reshaping the landscape of #hearingloss treatment, offering hope to families worldwide. Read more: fiercebiotech.com/biotech/little…
Modern #cropbreeding is evolving with precision, thanks to groundbreaking #geneediting technologies.
🧬 ✂️ 🌿
The review outlines the advancements in the field, covering technical innovation, and future research perspectives and challenges. More: phys.org/news/2024-04-a…
The dawn of therapeutic #cancervaccines . 🔬 Discover the innovative potential of this emerging field, with the help of captivating infographics from a recent article in Nature. 💉
nature.com/articles/d4158…
Exciting times ahead in biotech! 🔬 Check out this op-ed by Eric Schmidt on the imminent #ChatGPT moment in #biotech . Explore how #AI is reshaping the biotech landscape, accelerating #drugdiscovery , and transforming #healthcare as we know it:
time.com/6967625/we-nee…
From #cancer treatment to #climateresilient crops, #CRISPR is at the forefront of a #biotech revolution, offering solutions to pressing global challenges. 🧬✨
Explore CRISPR's transformative power in this article by World Economic Forum: weforum.org/agenda/2024/04…
Which technology will prevail as we transition away from fossil fuels? Leaps CEO Juergen Eckhardt explores the essential role #biofuels play in our #sustainablefuture and mentions Leaps portfolio company CoverCress Inc. in his latest Forbes op-ed. 🌾
Μore: forbes.com/sites/juergene…
For the first time, a person with #liverfailure is undergoing a revolutionary treatment that could potentially spawn a miniature liver within their lymph node, a temporary solution until a suitable donor organ becomes available. Read more :
#OrganShortage nature.com/articles/d4158…
This groundbreaking #CAR -T-based therapy for #glioblastoma , dubbed 'CAR-TEAM' cells, embodies the spirit of innovative #teamwork and unwavering dedication, representing a significant advancement in #cancerresearch and #brain tumor therapies. Read more: news.harvard.edu/gazette/story/…
📣 #Leaps #Portfolio news: Atomwise's #AI platform AtomNet is redefining what's possible in #drugdiscovery and opens doors to unprecedented opportunities in developing first-in-class and best-in-class therapies with a 74% success rate. 🔬
More: drugdiscoverytrends.com/why-atomwise-s…
📣 #Leapsportfolio news: CoverCress Inc. just won BloombergNEF Pioneers 2024 award in 'Creating #nextgeneration net-zero fuels' category.🏆 Congratulations, CoverCress Inc., your commitment to #greeninnovation is admirable. Thank you for leading the way! 🌏👏
bit.ly/3xuvI1M
#GenerativeAI is revolutionizing #drugdevelopment : Researchers Stanford Medicine just unveiled #SyntheMol , a revolutionary #AI model for #antibiotic discovery. 💊 They are now testing 6 novel drugs that can kill one of the most deadly bacteria. 📰 More: med.stanford.edu/news/all-news/…
The first two cell-based #genetherapies for treating #sicklecell disease, Casgevy and Lyfgenia, were approved in December by the #FDA .
Learn about the #opportunities and #benefits technologies like #CRISPR can bring for #patients and #science : bit.ly/3x6v22o